Results 31 to 40 of about 92,280 (267)
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
Frontiers in Marine ScienceWithin the framework of “One Country, Two Systems and Three Legal Jurisdictions,” managing cross-regional marine pollution in the Guangdong-Hong Kong-Macau Greater Bay Area encounters significant legal obstacles, including inconsistent regulations ...
Weirong Chen +3 more
doaj +1 more source
Intellectual property and control
Academic Medicine, 1993 The issue of intellectual property is viewed differently by different groups involved in biomedical research: researchers; academic institutions; corporate, government, and philanthropic sponsors; and society. The members of these groups do not always agree even among themselves; within government and academe, for instance, there are different and ...
openaire +4 more sources
On the prehistory of intellectual property [PDF]
, 2013 Full ...
Pottage, Alain, Sherman, Brad
openaire +2 more sources
Reconstructing enzyme evolution by protein engineering
FEBS Letters, EarlyView.Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler +2 more
wiley +1 more source
Indian Journal of Animal SciencesTo understand the innovation-based initiatives in the animal science sector, IP&TM Unit of ICAR has analysed IP management, and technology commercialization/licensing activities.
VIKRAM SINGH +2 more
doaj +1 more source
FEBS Letters, EarlyView.The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi +6 more
wiley +1 more source
Legal Aspects of Nanobiotechnology Inventions: An Indian Perspective
SCRIPTed: A Journal of Law, Technology & Society, 2009 Nanobiotechnology results from the convergence of nanotechnology and biotechnology. It has a remarkable potential to abate problems and provide efficient solutions related to medicine, the environment, agriculture etc. Nanobiotechnology applications have
Kanika Sharma, Archana Chugh
doaj +1 more source
Molecular Oncology, EarlyView.In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera +11 more
wiley +1 more source
Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer
Molecular Oncology, EarlyView.Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley +1 more source